PharmTeam

Seth Robey

Seth has always had a passion for scientific discovery, particularly biology and medicine. Seth studied biochemistry at Brandeis University. Now, as a PhD student of Molecular Pharmacology at Columbia University, Seth studies the drugs that help treat cardiac arrhythmias. He's thrilled to be a Motley Fool Contributor, and uncover new and exciting scientific discoveries that could improve our approach to medicine, and provide strong long term investments. Follow @SethRobey on twitter.

PharmTeam’s Activity

Thu Aug 21

Stock Advisor Boards Post

PharmTeam posted to the Stock Advisor boards. 9:33 AM

Wed Aug 20

NL

Article

PharmTeam published an article 5:59 PM

5 Things Eli Lilly and Co's Management Wants You to Know

At a critical time for the company, Eli Lilly's management has laid out its plans to return to growth and gave us a good look at what the future holds.

Thu Aug 14

NL

Article

PharmTeam published an article 11:31 AM

3 Building Blocks of a Wearable Technology Revolution

The sky is the limit for wearable medical technology, but it won't be as simple as slapping a smart watch on your wrist.

Wed Aug 13

Caps Pick

PharmTeam made a pick in CAPS. 9:47 AM

Arrowhead Research Corp (ARWR) will Outperform the S&P 500

Mon Aug 4

Rule Breakers Boards Post

PharmTeam posted to the Rule Breakers boards. 12:46 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 10:19 AM

Fri Jul 25

PharmTeam recommended TMFGebinr's post on a Motley Fool Stock Advisor board. 4:29 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 4:21 PM

Thu Jul 24

Stock Advisor Boards Post

PharmTeam replied to the Stock Advisor boards. 10:13 AM

Tue Jul 22

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 8:54 AM

Sat Jul 19

NL

Article

PharmTeam published an article 2:05 PM

10 Problems Electronic Health Records Can Help Solve

Electronic health records will be a central player in the future of health care and health care reform, and they may be even more useful than you might think.

Thu Jul 17

Caps Pick

PharmTeam made a pick in CAPS. 9:41 AM

Aegerion Pharmaceuticals, Inc. (AEGR) will Underperform the S&P 500

Thu Jul 10

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 11:10 PM

NL

Article

PharmTeam published an article 9:30 AM

Are Cancer Vaccines Worth an Investment?

Immuno-oncology has been the darling of biotech investors, but growth in one segment of the industry might not look as strong as you think.

Tue Jul 8

Stock Advisor Boards Post

PharmTeam posted to the Stock Advisor boards. 12:18 PM

Stock Advisor Boards Post

PharmTeam replied to the Stock Advisor boards. 10:48 AM

Sun Jul 6

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 8:40 PM

Thu Jul 3

Caps Pick

PharmTeam made a pick in CAPS. 12:40 PM

SolarCity (SCTY) will Outperform the S&P 500

Mon Jun 30

NL

Article

PharmTeam published an article 1:00 PM

Why Are Companion Diagnostics So Important?

Patients, doctors, and investors have been excited about new frontiers in oncology, but can these drugs be useful without companion diagnostics?

Sun Jun 22

PharmTeam recommended buyn2hold's post on a Motley Fool Rule Breakers board. 10:16 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 73.44
Player Rank 19929 out of 75032
Score 486.47
Score Change Today +25.52
Accuracy 52.05%
Active Picks 53
Total Picks 73
Best Pick ILMN (+130.58)
Worst Pick CYTK (-76.67)
Average Score per Pick 6.66
Charms Earned 4
Highest Rated Favorite No Favorites Selected
Go to PharmTeam’s CAPS page

Boards Stats & Trivia

Board Posts 26
Recs Received 24
People who have rec'd these posts 19
Recs to Posts Ratio (last 30 days) N/A
Threads Started 10
Threads Started Percentage 38.46 %
Most Frequent Board Motley Fool Rule Breakers
Very First Post A SAS: Amazon.com post. (12/1/2013)
Percentage of Posts Rec'd 46.15 %
Show PharmTeam’s 10 Latest Posts